Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Med. Technol.

Sec. Nano-Based Drug Delivery

Microbiome-based therapeutics for metabolic disorders: harnessing microbial intrusions for treatment

Provisionally accepted
Nafees AhmedNafees Ahmed1Vishwas GaurVishwas Gaur2Madhu KamleMadhu Kamle2Abhishek ChauhanAbhishek Chauhan3Ritu ChauhanRitu Chauhan4Pradeep KumarPradeep Kumar2*Namita Ashish SinghNamita Ashish Singh1*
  • 1Mohanlal Sukhadia University, Udaipur, India
  • 2University of Lucknow, Lucknow, India
  • 3Amity University Noida, Noida, India
  • 4Graphic Era Deemed to be University, Dehradun, India

This article is a correction to:

  1. Microbiome-based therapeutics for metabolic disorders: harnessing microbial intrusions for treatment

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Correction on: Ahmed N, Gaur V, Kamle M, Chauhan A, Chauhan R, Kumar P and Singh NA (2025) Microbiome-based therapeutics for metabolic disorders: harnessing microbial intrusions for treatment. Front. Med. Technol. 7:1695329. doi: 10.3389/fmedt.2025.1695329 Author affiliation

Keywords: Gut Microbiota, Dysbiosis, Metabolic disorder, diabetes, FMT, vaginal microbiota

Received: 31 Oct 2025; Accepted: 03 Nov 2025.

Copyright: © 2025 Ahmed, Gaur, Kamle, Chauhan, Chauhan, Kumar and Singh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Pradeep Kumar, pkbiotech@gmail.com
Namita Ashish Singh, namitas541@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material